On 14 July 2025 it was announced that Victoria will deliver a vaccination program to protect older adults from respiratory syncytial virus (RSV). The RSV vaccine Arexvy will be free for residents aged over 60 years in public and Aboriginal community-controlled aged care services.

RSV is a virus that causes upper and lower respiratory tract infections. Children under 1 year of age, those with underlying medical conditions, the older population and immunocompromised prople are more likely to experience serious disease causing hospitalisation.

RSV vaccines are currently recommended but not widely funded for all adults over 75 years, Aboriginal and Torres Strait Islander adults aged 60 to 74 years, and adults with specified medical conditions aged 60 to 74 years (Arexvy or Abrysvo).

RSV vaccination is recommended and funded for pregnant people from 28 weeks’ gestation (Abrysvo only).

Read more about the new program 这里

MVEC:呼吸道合胞病毒(RSV)
MVEC: Vaccine administration error alert: Incorrect RSV prevention product

MVEC acknowledges the traditional owners of the lands on which we live, work and educate. We pay our respects to their Elders, past, present and emerging.
We are committed to honouring Australian Aboriginal and Torres Strait Islander peoples’ unique cultural and spiritual relationships to the land, waters and seas.

关于 MVEC

墨尔本疫苗教育中心 (MVEC) 是一个教育网站,旨在为医疗保健专业人员和公众提供最新的免疫接种信息。我们位于研究机构默多克儿童研究所 (MCRI),隶属于维多利亚疫苗安全服务机构 SAEFVIC(社区接种疫苗后的不良事件监测)。

分享这个